(OTC: HRAL), (OTCBB: GNOLF), (NYSE: FLS).

RealPennies.com: Turning Pennies into dollars: (OTC: HRAL), (OTCBB: GNOLF), (NYSE: FLS).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://hral.realpennies.com

HearAtLast Holdings, Inc. (OTC: HRAL)(February 1, 2008) issued a press release announcing that that it has received another license from Wal-Mart Canada (NYSE: WMT) to open its 18th hearing-aid clinic which will be co-located within Wal-Mart Store #5778 located at 135 First Commerce Dr, Aurora, Ontario.

Great news from HRAL, as the store grand opening is scheduled for Tuesday, February the 5th, 2008. The Company currently owns and operates 17 hearing clinics co-located in Wal-Mart Stores, Wal-Mart Supercenters, and Sam's Clubs in Canada and one clinic in the U.S. in The Villages, Florida.

This expansion is a direct result of the Company exercising its option under a master licensing agreement with Wal-Mart Canada Corp., which allows HearAtLast to open hearing aid clinics within numerous Wal-Mart Stores, Wal-Mart Supercenters, and Sam's Club's throughout Canada.

"We are pleased to be opening our new clinic in the Town of Aurora," stated Mr. Robert J. Oswald, President of HearAtLast Holdings Inc. "Aurora has a key demographic for us with a large presence from both the automotive and insurance industries. With our continued expansion in Ontario, Alberta, and recently the U.S. market, our brand is thriving and there continues to be great new opportunities for our company."

HearAtLast Holdings, Inc. owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics co-located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.

For more info: http://gnolf.realpennies.com

Genoil Inc (OTCBB: GNOLF)(February 1, 2008) is an international engineering technology development company based in Alberta, Canada that develops innovative hydrocarbon, oil and water separation and marine technologies for the oil and gas and commercial marine industries. On Jan. 31st 2008, Genoil Inc. and Aquamation Inc. announced that site work at the Abeokuta Gas Metering Plants in Nigeria is underway and gas plant equipment is being installed. The plant is expected to be commissioned in 60 to 90 days.

For more info: http://fls.realpennies.com

Flowserve Corp. (NYSE: FLS) (February 1, 2008) is one of the world's leading providers of fluid motion and control products and services. Operating in more than 55 countries, the company produces engineered and industrial pumps, seals and valves as well as a range of related flow management services. On Jan. 31st 2008 the company announced a 2008 full year EPS target range of between $5.10 and $5.40. In addition, the company also provided additional details about its pending 2007 results, including backlog, revenue and operating margin improvement, as well as its market outlook. As previously announced, bookings for the fourth quarter 2007 were $1.1 billion and for full year 2007 were $4.3 billion, both up 19 percent. The company's backlog on December 31, 2007 was approximately $2.3 billion, which is the highest year end level in the company's history. The company expects full year 2007 revenue to be approximately $3.75 billion, exceeding the previously announced target range of $3.6 to $3.7 billion. Flowserve also expects 2007 full year operating margin to be at or near an annual improvement of 300 basis points, the high end of its previously announced range.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

(OTC: HRAL), (OTCBB: DNAG), (OTCBB: NNPP).

RealPennies.com: Turning Pennies into dollars: (OTC: HRAL), (OTCBB: DNAG), (OTCBB: NNPP).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://hral.realpennies.com

HearAtLast Holdings, Inc. (OTC: HRAL)February 4, 2008) rapid expansion should have investors closely monitoring the stock closely. Early this morning, the company issued a press release announcing that that it has received another license from Wal-Mart Canada (NYSE: WMT) to open its 18th hearing-aid clinic which will be co-located within Wal-Mart Store #5778 located at 135 First Commerce Dr, Aurora, Ontario.

Great news from HRAL, as the store grand opening is scheduled for Tuesday, February the 5th, 2008. The Company currently owns and operates 17 hearing clinics co-located in Wal-Mart Stores, Wal-Mart Supercenters, and Sam's Clubs in Canada and one clinic in the U.S. in The Villages, Florida.

This expansion is a direct result of the Company exercising its option under a master licensing agreement with Wal-Mart Canada Corp., which allows HearAtLast to open hearing aid clinics within numerous Wal-Mart Stores, Wal-Mart Supercenters, and Sam's Club's throughout Canada.

"We are pleased to be opening our new clinic in the Town of Aurora," stated Mr. Robert J. Oswald, President of HearAtLast Holdings Inc. "Aurora has a key demographic for us with a large presence from both the automotive and insurance industries. With our continued expansion in Ontario, Alberta, and recently the U.S. market, our brand is thriving and there continues to be great new opportunities for our company."

HearAtLast Holdings, Inc. owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics co-located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.

For more info: http://dnag.realpennies.com

DNAPrint Genomics, Inc. (OTCBB: DNAG) has developed, patented and published various technologies for an improved, 21st century model of clinical product development - aimed at maximizing effectiveness, minimizing unintended effects, reducing costs and shifting the risk to reward ratio during clinical product development. On Feb. 1st 2008, the company was pleased to announce a jointly signed letter of intent to be acquired by Nanobac Pharmaceuticals Inc. With the acquisition, which is subject to DNAPrint Genomics shareholder approval, Nanobac becomes one of a select group of next-generation drug and diagnostics developers, applying advanced computational methods and systematic genome-based approaches to streamline clinical product development. Nanobac adds advanced drug and diagnostics development programs, key patents and patent applications, and a proprietary product modeling platform to its existing initiatives, and expands its focus into multiple disease sites for both Diagnostics and Therapeutics.

For more info: http://nnpp.realpennies.com

Nano-Proprietary, Inc. (OTCBB: NNPP) is a holding company consisting of two wholly owned operating subsidiaries. Applied Nanotech Inc. is a premier research and commercialization organization dedicated to developing applications for nanotechnology with an extremely strong position in the fields of electron emission applications from carbon film/nanotubes, sensors, functionalized nanomaterials, and nanoelectronics.

On Jan. 31st 2008 the company announced that its subsidiary Applied Nanotech, Inc. will exhibit at "nano tech 2008" in Tokyo, Japan February 13 - 15, 2008. For additional information on this conference visit the conference website at http://www.ics-inc.co.jp/nanotech/en/index.html.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

(OTC: HRAL), (OTCBB: ACTC), (OTCBB: CNOA).

RealPennies.com: Turning Pennies into dollars: (OTC: HRAL), (OTCBB: ACTC), (OTCBB: CNOA).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://www.realpennies.com/HRAL.html

HearAtLast Holdings, Inc. (OTC: HRAL) (December 12, 2007) expansion should continue to have investors monitoring the stock closely. Early this morning, the company issued a press release announcing that it has received its 16th license from Wal-Mart Canada to open its 16th hearing-aid clinic to be co-located within the Sam's Club located at 255 Silver Linden Dr. in Richmond Hill, Ontario.

HearAtLast will utilize a specially designed, prefabricated, 220 square foot portable structure designed especially for Sam's Club locations. The modular design of this clinic will provide portability as it can be broken down and reassembled in various locations throughout the store as needed.

The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.


For more info: http://www.realpennies.com/ACTC.html

Advanced Cell Technology, Inc. (OTCBB: ACTC)(December 12, 2007) is a biotechnology company applying cellular technology in the emerging field of regenerative medicine. The company operates facilities in California and Massachusetts. On Dec. 6th 2007, the company announced that it is seeking international partners for each of its three lead therapeutic programs, including its Myoblast program for treating heart failure, its Retinal Pigment Epithelium program for treating degenerative retinal disease, and the Hemangioblast program for the treatment of blood and cardiovascular indications. The company is making significant progress in the development of each of these therapeutic programs within the United States.

For more info: http://www.realpennies.com/CNOA.html

China Organic Agriculture, Inc. (OTCBB: CNOA) (December 12, 2007) is among the largest producers of organic rice in China. CNOA controls all aspects of the process from seeds to planting and processing, R&D and sales. The Company also has an extensive sales network, located in the major cities in China. On Dec. 6th 2007, the company announced that the thay have reached a milestone 3-year retail distribution agreement with Shunda Grain and Oil Company of Songyuan City, one of the largest cities in the northeastern province of Jilin.

Read our full disclaimer at: http://www.realpennies.com

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on
http://www.realpennies.com/content/view/42

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com

RealPennies Hot Picks

RealPennies.com: Turning Pennies into dollars: (OTC: HRAL), (OTCBB: TPLM), (OTCBB: ACTC), (OTCBB: CNOA).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://www.realpennies.com/HRAL.html

HearAtLast Holdings, Inc. (OTC: HRAL) (December 10, 2007)has received its 15th license from Wal-Mart Canada to open its 15th hearing-aid clinic. Expansion should continue to have investors monitoring the stock closely. Early this morning, the company issued a press release announcing that it has received its 16th license from Wal-Mart Canada to open its 16th hearing-aid clinic to be co-located within the Sam's Club located at 255 Silver Linden Dr. in Richmond Hill, Ontario.

This is more great news for HRAL as the company continues its expansion! According to the press release, this expansion is a direct result of the Company exercising its option under a master licensing agreement with Wal-Mart Canada Corp. which allows HearAtLast to open hearing aid clinics within numerous Wal- Mart and Sam's locations throughout Canada. "It is an exciting time for us as we continue to add new locations throughout Canada." said Robert Oswald, President of HearAtLast. "We couldn't be more pleased with our roll-out in Canada thus far and we look forward to the opening of our first U.S. location in The Villages, Florida, this coming January of 2008." added Oswald.

HearAtLast will utilize a specially designed, prefabricated, 220 square foot portable structure designed especially for Sam's Club locations. The modular design of this clinic will provide portability as it can be broken down and reassembled in various locations throughout the store as needed.

While the company will continue co-location programs within the traditional Wal-Mart Stores as well as the Wal-Mart Super Centers, the new portable, prefabricated clinic model designed for Sam's, will allow HearAtLast to expand to new locations with relative ease. Management feels the dual model roll-out will afford the company flexibility as well as being a vital component to drive revenue growth.

HearAtLast Holdings, Inc. owns and operates its wholly-owned subsidiary HearAtLast Inc., a chain of hearing stores specializing in the sale of digital hearing aids and testing services. The company develops, owns, and operates hearing aid clinics co-located within select Wal-Mart stores throughout Canada. HearAtLast facilities sell a selection of high quality brand name hearing aids and also offer complimentary screening tests, clinical hearing tests, instant custom MP3 headphones and custom hearing protection. The Company's mission is to consolidate the highly fragmented hearing services industry while providing unparalleled service to the estimated 30+ million hearing impaired individuals throughout North America. After a prescription is approved, the independent on-site audiologists and hearing aid practitioners at HearAtLast utilize a refined process to dispense a hearing aid in about an hour.
For more info: http://www.realpennies.com/TPLM.html

Triangle Petroleum Corporation (OTCBB: TPLM)(December 10, 2007) is an exploration company focused on emerging Canadian shale gas projects, the Fayetteville shale gas project in Arkansas and select conventional oil projects in the Rocky Mountains. On Dec. 7th, the company announced that its third quarter fiscal 2008 earnings conference call will be held on Tuesday, December 11, 2007 at 11:00 a.m. eastern time. The Company will issue a press release on the same morning before the call covering financial and operational results for the quarter.

For more info: http://www.realpennies.com/ACTC.html

Advanced Cell Technology, Inc. (OTCBB: ACTC)(December 10, 2007) is a biotechnology company applying cellular technology in the emerging field of regenerative medicine. The company operates facilities in California and Massachusetts. On Dec. 6th 2007, the company announced that it is seeking international partners for each of its three lead therapeutic programs, including its Myoblast program for treating heart failure, its Retinal Pigment Epithelium program for treating degenerative retinal disease, and the Hemangioblast program for the treatment of blood and cardiovascular indications. The company is making significant progress in the development of each of these therapeutic programs within the United States.

For more info: http://www.realpennies.com/CNOA.html

China Organic Agriculture, Inc. (OTCBB: CNOA) (December 10, 2007) is among the largest producers of organic rice in China. CNOA controls all aspects of the process from seeds to planting and processing, R&D and sales. The Company also has an extensive sales network, located in the major cities in China. On Dec. 6th 2007, the company announced that the thay have reached a milestone 3-year retail distribution agreement with Shunda Grain and Oil Company of Songyuan City, one of the largest cities in the northeastern province of Jilin.

Read our full disclaimer at: http://www.realpennies.com

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on
http://www.realpennies.com/content/view/42

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice. Reproduction without written permission is prohibited.

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com